Identification of genes differentially expressed in benign prostatic hyperplasia.
Differences between benign prostatic hyperplasia (BPH) and normal prostate tissue at the level of mRNA expression provide an opportunity to identify candidate genes for this disease. A cDNA subtraction procedure was used to isolate differentially expressed genes in BPH. The subtraction was done by solution hybridization of BPH cDNA against excess normal prostate cDNA. We identified known, EST, and novel genes by sequence and database analysis of the subtracted cDNAs. Several of these cDNAs were used as probes in Northern blotting analysis to confirm over-expression of their corresponding mRNAs in BPH tissues. One highly upregulated sequence of interest shared identity with a known mRNA encoding human NELL2, a protein containing epidermal growth factor-like domains. NELL2 was not previously reported to be expressed in prostate and may code for a novel prostatic growth factor. In situ hybridization analysis of hyperplastic prostate specimens demonstrated that NELL2 mRNA expression is predominantly localized in basal cells of the epithelium. Disease-related changes in the levels of NELL2 may contribute to alterations in epithelial-stromal homeostasis in BPH. (J Histochem Cytochem 49:669-670, 2001)
DiLella
A G
AG
Departments of Pharmacology, Merck Research Laboratories, P.O. Box 4, West Point, PA 19486. tony_dilella@merck.com
Toner
T J
TJ
Austin
C P
CP
Connolly
B M
BM
D015152:Blotting, Northern; D018076:DNA, Complementary / Q000032:analysis; D005786:Gene Expression Regulation; D006801:Humans; D017403:In Situ Hybridization; D007781:Lactoferrin / Q000235:genetics / Q000378:metabolism; D008297:Male; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism*
D018076:DNA, Complementary; C104145:NELL2 protein, human; D009419:Nerve Tissue Proteins; D012333:RNA, Messenger; D007781:Lactoferrin